River Global Investors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-96,686
Closed -$15.4M 97
2014
Q4
$15.4M Sell
96,686
-52,912
-35% -$8.24M 3.79% 15
2014
Q3
$21M Sell
149,598
-38,494
-20% -$5.03M 4.14% 4
2014
Q2
$22.3M Buy
188,092
+2,500
+1% +$289K 5.8% 4
2014
Q1
$22.9M Sell
185,592
-14,671
-7% -$1.78M 5.36% 5
2013
Q4
$22.9M Sell
200,263
-15,770
-7% -$1.79M 5.65% 9
2013
Q3
$24.2M Buy
216,033
+72,728
+51% +$7.89M 5.44% 5
2013
Q2
$14.1M Buy
+143,305
New +$14.9M 2.29% 21

Other funds holding AMGN

River Global Investors's AMGN Position: Q1 2015 in Review

River Global Investors sold out of Amgen (AMGN) in Q1 2015, closing a stake of 96,686 shares — an estimated $15.4M sold.

River Global Investors first reported a position in AMGN in Q2 2013 and held it in 7 quarters. The position peaked at $24.2M in Q3 2013. 1,345 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • River Global Investors reported no remaining Amgen position as of Q1 2015 after selling out during the quarter.
  • River Global Investors sold 96,686 Amgen shares in Q1 2015, an estimated $15.4M.
  • River Global Investors first reported a position in Amgen in Q2 2013 and held it in 7 quarters.
  • River Global Investors's Amgen position peaked at $24.2M in Q3 2013.
  • 1,345 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on River Global Investors's 13F filing for Q1 2015, filed 14 Apr 2015.